Showing results (191-200 of 500) with videos related to

Sort By:
Pageof 50
Clinical Pharmacology and Therapeutics|October 10, 2003
Respiratory and miotic effects of morphine in healthy volunteers when P-glycoprotein is blocked by quinidineCarsten Skarke, Marwan Jarrar, Katharina Erb, et al.
Biochemical Pharmacology|February 12, 2022
Oxidized linoleic acid metabolites maintain mechanical and thermal hypersensitivity during sub-chronic inflammatory painSaskia Wedel, Tabea Osthues, Béla Zimmer, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 16, 2024
ALISTER - Application for lipid stability evaluation and researchSamuel Rischke, Robert Gurke, Alexandre Bennett, et al.
Pain|January 25, 2008
Low-dose methotrexate reduces peripheral nerve injury-evoked spinal microglial activation and neuropathic pain behavior in ratsJoachim Scholz, Andrea Abele, Claudiu Marian, et al.
Journal of Neurochemistry|April 26, 2021
Single intracerebroventricular progranulin injection adversely affects the blood-brain barrier in experimental traumatic brain injuryRegina Hummel, Manuel Lang, Simona Walderbach, et al.
Pharmacogenetics|January 5, 2002
The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphineJörn Lötsch, Carsten Skarke, Sabine Grösch, et al.
European Journal of Pharmacology|January 16, 2007
Impaired acute and inflammatory nociception in mice lacking the p50 subunit of NF-kappaBEllen Niederberger, Achim Schmidtko, Wei Gao, et al.
Basic Research in Cardiology|January 14, 2009
The S1P(2) receptor expressed in human platelets is linked to the RhoA-Rho kinase pathway and is down regulated in type 2 diabetesVoahanginirina Randriamboavonjy, Klaus Badenhoop, Helmut Schmidt, et al.
Pharmacogenomics|December 19, 2007
Pyrosequencing of polymorphisms in the COX-2 gene (PTGS2) with reported clinical relevanceCarsten Skarke, Patrick Schuss, Anja Kirchhof, et al.
Biochemical Pharmacology|June 15, 2004
Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cellsEllen Niederberger, Christine Manderscheid, Sabine Grösch, et al.
Pageof 50